Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 11
«Preious | of 3 |
1

抗癌治疗的VEGF靶向制剂的心血管安全性

Drug Evaluation, , Issue 27,2012, Pages 4-7, doi:10.3969/j.issn.1672-2809.2012.27.003

2

依立替康联合卡培他滨治疗晚期胃癌的临床观察

Drug Evaluation, , Issue 27,2012, Pages 36-4, doi:10.3969/j.issn.1672-2809.2012.27.010

3

1例胸腔积液患者误诊分析

Drug Evaluation, , Issue 27,2012, Pages 46-48, doi:10.3969/j.issn.1672-2809.2012.27.013

4

98例肺内单发小结节性病灶的诊治

Drug Evaluation, , Issue 27,2012, Pages 43-45, doi:10.3969/j.issn.1672-2809.2012.27.012

5

腮腺良性瘤术中保留腮腺咬肌筋膜预防Frey综合征的临床治疗

Drug Evaluation, , Issue 27,2012, Pages 28-3, doi:10.3969/j.issn.1672-2809.2012.27.008

Items 1-5 of 11
«Preious | of 3 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn